YD Bio YDES
NASDAQ YDES
$4.95 +0.71 (+16.75%)
At close: Oct 23, 2026 · 4:00 PM EDT

YD Bio (YDES) Cash & Current Investments (2024 - 2026)

Updated

YD Bio's Cash & Current Investments came in at $2.66 million for the quarter ended Jun 30, 2026, up 467.0% from $469,520 a year earlier.

Analysis

YD Bio (YDES) Cash & Current Investments (2024 - 2026) Analysis & Trends

As of Dec 31, 2025, YD Bio's Cash & Current Investments was $6.01 million, up 91.8% from the prior year.

  • Going back by year, Cash & Current Investments was $3.13 million in the year ended Dec 31, 2024.
  • The five-year range for quarterly Cash & Current Investments is $469,520 (the quarter ended Jun 30, 2025) to $6.01 million (the quarter ended Dec 31, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.23 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 6.57 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 11.70 Bn
10 YD Bio 350.41 Mn 338.14 Mn - 2.66 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.66 Mn
Dec 31, 2025 6.01 Mn
Jun 30, 2025 469,520.00
Dec 31, 2024 3.13 Mn
API Access

YD Bio Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=YDES&period=max&api_key=YOUR_API_KEY